secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2026-07-21T20:05:30+00:00
Accession:  0001493152-26-034079
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals CMO Dr. Gregory Sullivan to retire effective Aug 20, 2026
-------------------------------------------------------------------------------

- Dr. Gregory M. Sullivan informed Tonix of his retirement as Chief Medical Officer.
- Retirement effective August 20, 2026.
- No successor has been named as of the filing date.
- Departure is a planned retirement, not a termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226034079/0001493152-26-034079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226034079/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer